Afghanistan vs Lao People's Democratic Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Afghanistan
63.0%
in 2025
Lao People's Democratic Republic
62.0%
in 2025
Afghanistan rank
142nd
Lao People's Democratic Republic rank
144th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Afghanistan
- Lao People's Democratic Republic
How they compare
Afghanistan currently reports 63.0% against 62.0% in Lao People's Democratic Republic, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Lao People's Democratic Republic ahead.
Afghanistan ranks 142nd and Lao People's Democratic Republic ranks 144th of 194 countries.
Lao People's Democratic Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 36.3% | 42.9% | 6.6% | Lao People's Democratic Republic |
| 2020s | 59.2% | 62.3% | 3.2% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Afghanistan or Lao People's Democratic Republic?
- Afghanistan, at 63.0% against 62.0% in Lao People's Democratic Republic as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Afghanistan and Lao People's Democratic Republic?
- 1.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Lao People's Democratic Republic?
- 18 years are reported by both, from 2008 to 2025.
- How do Afghanistan and Lao People's Democratic Republic rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Afghanistan ranks 142nd and Lao People's Democratic Republic ranks 144th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.